Mimics of pancreatic ductal adenocarcinoma.

PubWeight™: 0.84‹?›

🔗 View Article (PMC 3800430)

Published in Cancer Imaging on September 23, 2013

Authors

Mahmoud M Al-Hawary1, Ravi K Kaza, Shadi F Azar, Julie A Ruma, Isaac R Francis

Author Affiliations

1: Department of Radiology, University of Michigan Health Services, Ann Arbor, MI, USA.

Articles cited by this

CT features of the accessory spleen. AJR Am J Roentgenol (2004) 2.81

MR imaging features of solid pseudopapillary tumor of the pancreas in adult and pediatric patients. AJR Am J Roentgenol (2003) 1.83

Acinar cell carcinoma of the pancreas: computed tomography features--a study of 15 patients. Abdom Imaging (2013) 1.59

Imaging features of solitary fibrous tumors. AJR Am J Roentgenol (2011) 1.58

Annular pancreas in adults. AJR Am J Roentgenol (2009) 1.57

Lymphoplasmacytic sclerosing pancreatitis with obstructive jaundice: CT and pathology features. AJR Am J Roentgenol (2004) 1.47

IgG4-related sclerosing disease: autoimmune pancreatitis and extrapancreatic manifestations. Radiographics (2011) 1.38

Complications of congenital and developmental abnormalities of the gastrointestinal tract in adolescents and adults: evaluation with multimodality imaging. Radiographics (2010) 1.33

Abdominal manifestations of extranodal lymphoma: spectrum of imaging findings. AJR Am J Roentgenol (2008) 1.27

Solid pancreatic hamartoma. Pathol Int (2007) 1.22

Pancreatic pseudotumors: non-neoplastic solid lesions of the pancreas that clinically mimic pancreas cancer. Semin Diagn Pathol (2004) 1.21

A comprehensive, case-based review of groove pancreatitis. Pancreas (2009) 1.15

Pancreatic parenchymal metastases: observations on helical CT. AJR Am J Roentgenol (2001) 1.09

Duct-penetrating sign at MRCP: usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas. Radiology (2001) 1.07

Pancreatic and peripancreatic diseases mimicking primary pancreatic neoplasia. Radiographics (2005) 1.07

A clinical and radiologic review of uncommon types and causes of pancreatitis. Radiographics (2009) 1.07

Pancreatic imaging mimics: part 1, imaging mimics of pancreatic adenocarcinoma. AJR Am J Roentgenol (2012) 0.99

Extranodal lymphoma from head to toe: part 2, the trunk and extremities. AJR Am J Roentgenol (2011) 0.97

Pancreatic mass due to chronic pancreatitis: correlation of CT and MR imaging features with pathologic findings. AJR Am J Roentgenol (2001) 0.96

CT of serous cystadenoma of the pancreas and mimicking masses. AJR Am J Roentgenol (2008) 0.94

A focal mass-forming autoimmune pancreatitis mimicking pancreatic cancer with obstruction of the main pancreatic duct. J Gastrointest Surg (2011) 0.93

Metastases to the pancreas: the experience of a high volume center and a review of the literature. J Surg Oncol (2011) 0.92

The spectrum of hematologic malignancies involving the pancreas: potential clinical mimics of pancreatic adenocarcinoma. Am J Clin Pathol (2012) 0.90

Pancreatic imaging mimics: part 2, pancreatic neuroendocrine tumors and their mimics. AJR Am J Roentgenol (2012) 0.90

Imaging of chronic pancreatitis (including groove and autoimmune pancreatitis). Radiol Clin North Am (2012) 0.88

Imaging features of hematogenous metastases to the pancreas: pictorial essay. Cancer Imaging (2011) 0.87

CT imaging features of acinar cell carcinoma and its hepatic metastases. Abdom Imaging (2013) 0.86

Use of molecular targeted agents for the diagnosis, staging and therapy of neuroendocrine malignancy. Cancer Imaging (2010) 0.85

Atypical manifestations of IgG4-related sclerosing disease in the abdomen: imaging findings and pathologic correlations. AJR Am J Roentgenol (2013) 0.85

Part 2: CT characterisation of pancreatic neoplasm: tumour mimics. Insights Imaging (2011) 0.80

Serous neoplasms of the pancreas constitute a continuous spectrum of morphological patterns rather than distinct clinico-pathological variants. A study of 40 cases. Pol J Pathol (2011) 0.79

Uncommon tumors and pseudotumoral lesions of the pancreas. Curr Probl Diagn Radiol (2008) 0.78

Unusual solid pancreatic tumors. Radiol Clin North Am (2012) 0.77

Articles by these authors

Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee. J Am Coll Radiol (2010) 4.15

Adrenal masses: characterization with combined unenhanced and delayed enhanced CT. Radiology (2002) 2.67

Comparison of acute transient dyspnea after intravenous administration of gadoxetate disodium and gadobenate dimeglumine: effect on arterial phase image quality. Radiology (2012) 2.53

Frequency, outcome, and appropriateness of treatment of nonionic iodinated contrast media reactions. AJR Am J Roentgenol (2008) 2.29

Urinary tract abnormalities: initial experience with multi-detector row CT urography. Radiology (2002) 2.23

Abdominal CT with model-based iterative reconstruction (MBIR): initial results of a prospective trial comparing ultralow-dose with standard-dose imaging. AJR Am J Roentgenol (2012) 2.13

Age-related immune dysfunction in health and in human immunodeficiency virus (HIV) disease: association of age and HIV infection with naive CD8+ cell depletion, reduced expression of CD28 on CD8+ cells, and reduced thymic volumes. J Infect Dis (2003) 1.97

Imaging manifestations of Meckel's diverticulum. AJR Am J Roentgenol (2007) 1.65

T2-weighted MR imaging in the assessment of cirrhotic liver. Radiology (2004) 1.61

A phase I/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine (FDR-G) in patients with unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys (2012) 1.60

Typical and atypical presentations of extramedullary hemopoiesis. AJR Am J Roentgenol (2002) 1.52

Repeatability of diagnostic features and scoring systems for hepatocellular carcinoma by using MR imaging. Radiology (2014) 1.52

Differentiation of papillary renal cell carcinoma subtypes on CT and MRI. AJR Am J Roentgenol (2013) 1.47

Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study. Radiology (2005) 1.44

Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study. Radiology (2003) 1.42

Medical decision making regarding computed tomographic radiation dose and associated risk: the patient's perspective. Arch Intern Med (2009) 1.31

Can CT features be used to diagnose surgical adult bowel intussusceptions? AJR Am J Roentgenol (2009) 1.21

Lack of tumor seeding of hepatocellular carcinoma after percutaneous needle biopsy using coaxial cutting needle technique. AJR Am J Roentgenol (2006) 1.17

A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer. Cancer (2013) 1.16

MRI of adrenal and extraadrenal pheochromocytoma. AJR Am J Roentgenol (2005) 1.16

Improved characterization of focal liver lesions with liver-specific gadoxetic acid disodium-enhanced magnetic resonance imaging: a multicenter phase 3 clinical trial. J Comput Assist Tomogr (2010) 1.10

The prediction of radiation-induced liver dysfunction using a local dose and regional venous perfusion model. Med Phys (2007) 1.09

Liver function after irradiation based on computed tomographic portal vein perfusion imaging. Int J Radiat Oncol Biol Phys (2007) 1.08

Ultrasound imaging of bowel pathology: technique and keys to diagnosis in the acute abdomen. AJR Am J Roentgenol (2011) 1.08

Phase I study of oxaliplatin, full-dose gemcitabine, and concurrent radiation therapy in pancreatic cancer. J Clin Oncol (2007) 1.08

Incidence of acute appendicitis in patients with equivocal CT findings. AJR Am J Roentgenol (2005) 1.04

Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid as an intrabiliary contrast agent: preliminary assessment. AJR Am J Roentgenol (2002) 1.03

Long-term changes in circulating CD4 T lymphocytes in virologically suppressed patients after 6 years of highly active antiretroviral therapy. AIDS (2004) 1.03

Volume reduction versus radiation dose for tumors in previously untreated lymphoma patients who received iodine-131 tositumomab therapy. Conjugate views compared with a hybrid method. Cancer (2002) 1.01

Distinct mechanisms of T cell reconstitution can be identified by estimating thymic volume in adult HIV-1 disease. J Infect Dis (2005) 1.00

Pneumatosis and portal venous gas: do CT findings reassure? J Surg Res (2013) 1.00

Nephrogenic systemic fibrosis: a report of 29 cases. AJR Am J Roentgenol (2008) 0.99

Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the Society of Abdominal Radiology and the American Pancreatic Association. Radiology (2014) 0.98

Multimodality diagnosis of liver tumors: feature analysis with CT, liver-specific and contrast-enhanced MR, and a computer model. Acad Radiol (2002) 0.98

Effectiveness of MR imaging in characterizing small hepatic lesions: routine versus expert interpretation. AJR Am J Roentgenol (2003) 0.97

Interventional therapies for hepatocellular carcinoma. Cancer Imaging (2012) 0.93

Matched within-patient cohort study of transient arterial phase respiratory motion-related artifact in MR imaging of the liver: gadoxetate disodium versus gadobenate dimeglumine. Radiology (2014) 0.92

Renal vein leiomyosarcoma: imaging and clinical features of a renal cell carcinoma mimic. Abdom Imaging (2013) 0.92

Rectal imaging: part 2, Perianal fistula evaluation on pelvic MRI--what the radiologist needs to know. AJR Am J Roentgenol (2012) 0.92

Multidetector CT imaging in mesenteric ischemia--pearls and pitfalls. Emerg Radiol (2010) 0.90

Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the society of abdominal radiology and the american pancreatic association. Gastroenterology (2014) 0.90

Biliary imaging with Gd-EOB-DTPA: is a 20-minute delay sufficient? Acad Radiol (2002) 0.90

"Sweet spot" for endoleak detection: optimizing contrast to noise using low keV reconstructions from fast-switch kVp dual-energy CT. J Comput Assist Tomogr (2012) 0.89

MRI for preoperative staging of renal cell carcinoma using the 1997 TNM classification: comparison with surgical and pathologic staging. AJR Am J Roentgenol (2004) 0.89

Non-invasive evaluation of the incidentally detected indeterminate adrenal mass. Best Pract Res Clin Endocrinol Metab (2005) 0.89

Primary and secondary disease of the peritoneum and mesentery: review of anatomy and imaging features. Abdom Imaging (2015) 0.89

Making cost-effectiveness analyses clinically relevant: the effect of provider expertise and biliary disease prevalence on the economic comparison of alternative diagnostic strategies. Acad Radiol (2003) 0.88

Hepatic arterial phase MR imaging with automated bolus-detection three-dimensional fast gradient-recalled-echo sequence: comparison with test-bolus method. Radiology (2003) 0.88

Imaging appearance of renal epithelioid angiomyolipomas. J Comput Assist Tomogr (2013) 0.87

Comparison of urinary tract distension and opacification using single-bolus 3-Phase vs split-bolus 2-phase multidetector row CT urography. J Comput Assist Tomogr (2007) 0.87

Magnetic resonance imaging features of renal synovial sarcoma: a case report. Cancer Imaging (2008) 0.87

Gemcitabine-based combination chemotherapy followed by radiation with capecitabine as adjuvant therapy for resected pancreas cancer. Int J Radiat Oncol Biol Phys (2009) 0.87

CT appearances following laparoscopic partial nephrectomy for renal cell carcinoma using a rolled cellulose bolster. Cancer Imaging (2010) 0.86

Evaluation of imaging-guided core biopsy of pancreatic masses. AJR Am J Roentgenol (2006) 0.85

Imaging of pancreas transplants: postoperative findings with clinical correlation. J Comput Assist Tomogr (2009) 0.85

Characterization of adrenal masses with diffusion-weighted imaging. AJR Am J Roentgenol (2011) 0.85

Older HIV-infected patients on antiretroviral therapy have B-cell expansion and attenuated CD4 cell increases with immune activation reduction. AIDS (2013) 0.85

Multimodality imaging in ureteric and periureteric pathologic abnormalities. AJR Am J Roentgenol (2011) 0.84

Evaluation of imaging-guided core biopsy of pelvic masses. AJR Am J Roentgenol (2007) 0.84

CT enterography: concepts and advances in Crohn's disease imaging. Radiol Clin North Am (2013) 0.83

Imaging effects of radiation therapy in the abdomen and pelvis: evaluating "innocent bystander" tissues. Radiographics (2013) 0.82

Extra Z-axis coverage at CT imaging resulting in excess radiation dose: frequency, degree, and contributory factors. J Comput Assist Tomogr (2011) 0.82

The indeterminate adrenal lesion. Cancer Imaging (2010) 0.82

Vascular pancreatic lesions: spectrum of imaging findings of malignant masses and mimics with pathologic correlation. Abdom Imaging (2013) 0.82

3D excretory MR urography: improved image quality with intravenous saline and diuretic administration. J Magn Reson Imaging (2007) 0.81

Multimodality imaging of splenic lesions and the role of non-vascular, image-guided intervention. Abdom Imaging (2014) 0.81

CT imaging characteristics of oncocytic adrenal neoplasms (OANs): comparison with adrenocortical carcinomas. Abdom Imaging (2014) 0.81

Imaging of acute pancreatitis: prognostic value of computed tomographic findings. J Comput Assist Tomogr (2010) 0.81

Detection of upper tract urothelial neoplasms: sensitivity of axial, coronal reformatted, and curved-planar reformatted image-types utilizing 16-row multi-detector CT urography. Abdom Imaging (2008) 0.81

Imaging and management of the incidentally discovered renal mass. Cancer Imaging (2009) 0.80

Prognostic significance of carbohydrate antigen 19-9 in unresectable locally advanced pancreatic cancer treated with dose-escalated intensity modulated radiation therapy and concurrent full-dose gemcitabine: analysis of a prospective phase 1/2 dose escalation study. Int J Radiat Oncol Biol Phys (2012) 0.80

Computed tomography appearances of hypervascular hepatic tumors after percutaneous radiofrequency ablation therapy. Curr Probl Diagn Radiol (2002) 0.80

MR imaging in the characterization of small renal masses. Abdom Imaging (2014) 0.79

MR imaging of the pelvis: a guide to incidental musculoskeletal findings for abdominal radiologists. Abdom Imaging (2014) 0.79

Evaluation of low-dose CT angiography with model-based iterative reconstruction after endovascular aneurysm repair of a thoracic or abdominal aortic aneurysm. AJR Am J Roentgenol (2014) 0.79

Comparative investigation of i.v. iohexol and iopamidol: effect on renal function in low-risk outpatients undergoing CT. AJR Am J Roentgenol (2012) 0.79

Adrenal Incidentaloma triage with single-source (fast-kilovoltage switch) dual-energy CT. AJR Am J Roentgenol (2014) 0.78

Radiologic evaluation of incidentally discovered adrenal masses. Am Fam Physician (2010) 0.77

Aortic endograft surveillance: use of fast-switch kVp dual-energy computed tomography with virtual noncontrast imaging. J Comput Assist Tomogr (2011) 0.77

A guide to imaging in bariatric surgery. Emerg Radiol (2013) 0.77

Pancreatic ductal adenocarcinoma staging. Cancer Imaging (2013) 0.76

Staging of pancreatic cancer: role of imaging. Semin Roentgenol (2013) 0.76

Radiation therapy with full-dose gemcitabine and oxaliplatin for unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys (2011) 0.76

Personalized dose reduction for computed tomography scanning: size matters, so does prior radiation exposures. Clin Gastroenterol Hepatol (2009) 0.75

Apparent wall thickening of cystic renal lesions on MRI. J Magn Reson Imaging (2008) 0.75

White Paper of the Society of Computed Body Tomography and Magnetic Resonance on Dual-Energy CT, Part 1: Technology and Terminology. J Comput Assist Tomogr (2016) 0.75

White Paper of the Society of Computed Body Tomography and Magnetic Resonance on Dual-Energy CT, Part 3: Vascular, Cardiac, Pulmonary, and Musculoskeletal Applications. J Comput Assist Tomogr (2017) 0.75

Variability in computed tomography diameter measurements of solid renal masses. Abdom Imaging (2014) 0.75

ACR appropriateness criteria on obstructive voiding symptoms secondary to prostate disease. J Am Coll Radiol (2010) 0.75

Hepatic imaging for metastatic disease. Cancer J (2010) 0.75